🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II/III trial studies the side effects of nivolumab and ipilimuma...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-11-23
Trial ID
NCT02339571
This phase I trial tests the safety, side effects, and best dose of intrape...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-12-31
Trial ID
NCT06269978
This phase II MATCH treatment trial identifies the effects of copanlisib hy...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2018-06-20
Trial ID
NCT05490771
Treatments Being Tested
This phase II trial tests how well 177Lu-PSMA-617 works in treating patient...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-04-29
Trial ID
NCT06526299
The purpose of this study is to determine if individuals with serious menta...
Status
Completed
Location
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Start Date
2010-03
Trial ID
NCT00677898
Treatments Being Tested
This phase III trial studies whether pembrolizumab alone as a first-line tr...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2019-04-05
Trial ID
NCT03793179
This phase II trial studies how well vedolizumab plus post-transplant cyclo...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-04-18
Trial ID
NCT06815003
This phase II trial tests the effect of endoscopic ultrasound (EUS)-guided ...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-05-12
Trial ID
NCT07529483
This phase I/II trial tests the safety and effectiveness of extramedullary ...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-08-29
Trial ID
NCT06572605
This phase I trial tests the safety, tolerability and impact of adding prop...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2026-05-15
Trial ID
NCT06670976